• 1. Excitation energies from ground-state density-functionals by means of generator coordinates
  A. B. F. da Silva,K. Capelle Phys. Chem. Chem. Phys., 2009,11, 4564-4569
• 2. Evolutionary de novo design of phenothiazine derivatives for dye-sensitized solar cells?
  Vishwesh Venkatraman,Marco Foscato,Vidar R. Jensen,Bj?rn K?re Alsberg J. Mater. Chem. A, 2015,3, 9851-9860
• 3. Emulsion soft templating of carbide-derived carbon nanospheres with controllable porosity for capacitive electrochemical energy storage?
  M. Zeiger,N. J?ckel,P. Strubel,L. Borchardt,R. Reinhold,W. Nickel,J. Eckert,V. Presser,S. Kaskel J. Mater. Chem. A, 2015,3, 17983-17990
• 4. Fe(iii)-mediated isomerization of α,α-diarylallylic alcohols to ketones via radical 1,2-aryl migration?
  Ziyang Deng,Changwei Chen,Sunliang Cui RSC Adv., 2016,6, 93753-93755
• 5. Excess electrons in lithium–ethylamine solutions—density, electrical conductivity and EPR studies
  Phys. Chem. Chem. Phys., 1999,1, 3561-3565

• Solvents and Organic Chemicals Organic Compounds Organic nitrogen compounds Organonitrogen compounds Amines Tertiary amines

Introduction to 2,4-Pyrimidinediamine,N2,N2,N4,N4-tetramethyl (CAS No. 1076-94-4) and Its Recent Applications in Chemical Biology

The compound 2,4-Pyrimidinediamine,N2,N2,N4,N4-tetramethyl (CAS No. 1076-94-4) represents a fascinating derivative of the pyrimidine scaffold, a heterocyclic structure that has long been recognized for its biological significance and pharmaceutical relevance. Pyrimidines are fundamental components of nucleic acids, and their derivatives have been extensively explored in drug discovery due to their ability to interact with biological targets in a highly specific manner. The N,N,N',N'-tetramethyl substitution pattern in this compound introduces unique electronic and steric properties, making it a valuable scaffold for developing novel bioactive molecules.

In recent years, the field of chemical biology has witnessed significant advancements in the design and application of pyrimidine-based compounds. The 2,4-Pyrimidinediamine,N2,N2,N4,N4-tetramethyl derivative has emerged as a promising candidate for various therapeutic applications, particularly in the realm of enzyme inhibition and receptor binding studies. Its structural features allow for precise tuning of interactions with biological macromolecules, which is crucial for achieving high selectivity and efficacy in drug development.

One of the most compelling aspects of this compound is its potential as an inhibitor of enzymes involved in cancer metabolism. Recent studies have highlighted the importance of metabolic reprogramming in tumor cells, where enzymes such as kinases and dehydrogenases play a critical role in sustaining cancer growth. The N2,N2,N4,N4-tetramethyl substitution on the pyrimidine ring enhances the compound's ability to bind to these enzymes, thereby disrupting key metabolic pathways. For instance, preliminary research suggests that this derivative may interfere with the activity of pyruvate kinase, an enzyme central to glycolysis, which is often upregulated in cancer cells.

Moreover, the compound has shown promise in preclinical studies as a modulator of signal transduction pathways. Pyrimidine derivatives are known to interact with a variety of protein targets, including receptors and transcription factors. The tetramethyl groupation pattern on 2,4-Pyrimidinediamine appears to enhance its binding affinity to certain proteins while minimizing off-target effects. This specificity is particularly valuable in drug development, where unintended interactions can lead to adverse side effects.

Another area where this compound has garnered attention is in the development of antiviral agents. Viruses often rely on host cellular machinery for replication, and targeting these processes with small molecules can be an effective strategy for antiviral therapy. The structural similarity of pyrimidine derivatives to natural nucleobases allows them to compete with viral nucleic acids during replication. Research indicates that the N2,N2,N4,N4-tetramethyl modification may improve the stability and bioavailability of such derivatives, enhancing their antiviral potency.

The synthesis of 2,4-Pyrimidinediamine,N2,N2,N4,N4-tetramethyl (CAS No. 1076-94-4) involves multi-step organic transformations that highlight the ingenuity of modern synthetic chemistry. The introduction of methyl groups at specific positions requires precise control over reaction conditions to ensure regioselectivity. Advances in catalytic methods have made it possible to achieve these transformations with higher yields and cleaner reaction profiles, which is essential for large-scale production.

In conclusion, the compound 2,4-Pyrimidinediamine,N2,N2,N4,N4-tetramethyl (CAS No. 1076-94-4) represents a significant advancement in the field of chemical biology and drug discovery. Its unique structural features and biological activities make it a versatile tool for exploring new therapeutic strategies against various diseases. As research continues to uncover new applications for this derivative, it is likely to play an increasingly important role in the development of next-generation pharmaceuticals.

• 24867-24-1(pyrimidine, 2,4-diamino-6-(methylamino)- (8ci))
• 36314-80-4(N4,N4-dimethylpyrimidine-4,6-diamine)
• 22404-42-8(N-(4-Aminopyridin-2-yl)-N-methylamine)
• 22632-10-6(N-methylpyrimidin-4-amine)
• 56797-20-7(2,4,6-Pyrimidinetriamine, N,N',N''-trimethyl-)
• 1074-34-6(4-Imino-N,N-dimethyl-1,4-dihydropyrimidin-2-amine)
• 31401-45-3(N,N-Dimethylpyrimidin-4-amine)
• 1004-18-8(N4-Methylpyrimidine-2,4-diamine)
• 1005-26-1(N4,N4-dimethylpyrimidine-2,4-diamine)
• 66131-72-4(4-N,6-N-dimethylpyrimidine-4,6-diamine)